Johnson & Johnson (JNJ) Stock Surges Past Record High as Wall Street Raises Price Targets
The post Johnson & Johnson (JNJ) Stock Surges Past Record High as Wall Street Raises Price Targets appeared on BitcoinEthereumNews.com. Key Highlights JNJ reached a record peak of $264.98 before climbing further to $268.69, posting a 3.70% daily gain Year-over-year total returns stand at an impressive 71% Guggenheim elevated its price objective to $270 with a Buy rating, projecting Q2 sales of $25.48 billion The company increased its quarterly payout to $1.34 per share from $1.30, extending its dividend growth streak to 55 years Major institutional players including Vanguard, State Street, and Norges Bank have significantly expanded their stakes Johnson & Johnson shares reached unprecedented territory on Tuesday, initially touching $264.98 before advancing to $268.69 — representing a 3.70% intraday increase. This valuation positions the healthcare giant’s market capitalization at approximately $646.8 billion. Johnson & Johnson, JNJ Over the trailing twelve-month period, shares have cli